AN2 Therapeutics, Inc. ($ANTX)
Filing Information
| Accession Number | 0001193125-26-389545 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 11, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
1,108
Total Value
$6,674.92
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 9, 2026 | Sale | 523 | $6.02 | $3,150.71 | 557,467 | Indirect | See footnotes | View Details | |
Director | Common Stock | โ | Sep 9, 2026 | Sale | 585 | $6.02 | $3,524.22 | 624,765 | Indirect | See footnotes | View Details |